X-ZELL Blog Episode 3

X-ZELL Blog Explained: The early detection paradox Even though the notion of discovering prostate cancer early may seem intriguing from a patient perspective, the topic has been dividing the medical community for decades. The sticking point is a simple question – how...

X-ZELL launches global Cryoimmunostaining™ technology trial

Applications for global Cryoimmunostaining™ technology trial now open Bangkok, July 2018 – After successfully completing a series of clinical trials across Southeast Asia, rare cell detection specialist X-ZELL Inc. is now making the company’s patented...

X-ZELL CEO to present at APCC 2018

X-ZELL CEO to present at Asia-Pacific Prostate Cancer Conference Brisbane, July 2018 – X-ZELL Inc. CEO, Dr Sebastian Bhakdi, will use the upcoming Asia-Pacific Prostate Cancer Conference (APCC) in Brisbane next month as a platform to reveal “exciting new insights”...